Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma

Source: BMC Cancer - Category: Cancer & Oncology Authors: Tags: Correction Source Type: research